Institut de La Main, Clinique Bizet, Paris Shoulder Unit, Paris, France.
Int Orthop. 2024 Dec;48(12):3159-3166. doi: 10.1007/s00264-024-06296-0. Epub 2024 Sep 27.
To report the radiological and clinical outcomes of non-vascularized coracoid process autografts used for glenoid reconstruction during revision shoulder arthroplasty.
This is a retrospective, monocentric study from January 2016 to October 2022 targeting patients treated with a coracoid bone graft for glenoid reconstruction during revision of shoulder arthroplasty. The primary outcome measures were coracoid graft union rate and graft-implant osseointegration. Secondary outcome measures included clinical and CT-scan identified radiological complications and functional outcomes as measured by the Visual Analog Scale (VAS), Range of Motion (ROM), Subjective Shoulder Value (SSV), Constant score (absolute and ponderate), and ASES score.
Fifteen patients (9 males, 6 females; mean age 66.9 years, range 38-85) were included. At a mean follow-up of 20.9 months (range 12-56 months), 93.3% achieved complete graft integration. One case of partial lysis without baseplate loosening was noted. Regarding range of motion, the mean forward elevation was 130° (range 90°-170°), external rotation at the side 25° (range 10°-40°), external rotation in 90° of abduction 45° (range 10°-80°), and internal rotation 52° (range 10-80°). The mean VAS for pain was 1.1 (range 0-8), mean SSV 67.3% (range 40-90%), mean ASES score 85.5 (range 65-98.3), mean Absolute Constant score 58.6 (range 21-83), and mean Ponderate Constant score 77.5% (range 28.8-110.7%). No neurological injuries were reported.
Utilizing a non-vascularized coracoid graft during shoulder arthroplasty revision is a safe, reproducible, and time-efficient technique that demonstrated satisfactory osseointegration, implant stability, good functional results, and a low complication rate.
报告在肩关节翻修术中使用非血管化喙突移植物进行盂唇重建的放射学和临床结果。
这是一项回顾性、单中心研究，纳入了 2016 年 1 月至 2022 年 10 月期间因肩关节置换翻修而接受喙突骨移植进行盂唇重建的患者。主要结局指标为喙突移植物的愈合率和移植物-植入物骨整合。次要结局指标包括临床和 CT 扫描确定的放射学并发症以及通过视觉模拟量表（VAS）、活动范围（ROM）、主观肩部值（SSV）、Constant 评分（绝对值和加权值）和 ASES 评分测量的功能结果。
共纳入 15 例患者（9 例男性，6 例女性；平均年龄 66.9 岁，范围 38-85 岁）。平均随访 20.9 个月（范围 12-56 个月），93.3%的患者实现了完全移植物整合。仅 1 例出现基底松动的部分骨溶解。在运动范围方面，平均前向抬高 130°（范围 90°-170°），侧方外旋 25°（范围 10°-40°），外展 90°外旋 45°（范围 10°-80°），和内旋 52°（范围 10°-80°）。平均疼痛 VAS 为 1.1（范围 0-8），平均 SSV 为 67.3%（范围 40-90%），平均 ASES 评分为 85.5（范围 65-98.3），平均绝对 Constant 评分为 58.6（范围 21-83），平均加权 Constant 评分为 77.5%（范围 28.8-110.7%）。未报告神经损伤。
在肩关节置换翻修术中使用非血管化喙突移植物是一种安全、可重复且高效的技术，具有令人满意的骨整合、植入物稳定性、良好的功能结果和较低的并发症发生率。
